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for identifying patients with significant CAD. METHODS AND RESULTS: A total of 475 patients with
stable chest pain and intermediate likelihood of CAD underwent coronary computed tomographic an-
giography and stress myocardial perfusion imaging by single photon emission computed tomography or
positron emission tomography, and ventricular wall motion imaging by stress echocardiography or car-
diac magnetic resonance. If ￿1 test was abnormal, patients underwent invasive coronary angiography.
Significant CAD was defined by invasive coronary angiography as >50% stenosis of the left main stem,
>70% stenosis in a major coronary vessel, or 30% to 70% stenosis with fractional flow reserve ￿0.8. Signif-
icant CAD was present in 29% of patients. In a patient-based analysis, coronary computed tomographic
angiography had the highest diagnostic accuracy, the area under the receiver operating characteristics
curve being 0.91 (95% confidence interval, 0.88-0.94), sensitivity being 91%, and specificity being 92%.
Myocardial perfusion imaging had good diagnostic accuracy (area under the curve, 0.74; confidence in-
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under the curve, 0.70; confidence interval, 0.65-0.75) but lower sensitivity (49%, P<0.001) and higher
specificity (92%, P<0.001). The diagnostic accuracy of myocardial perfusion imaging and wall motion
imaging were lower than that of coronary computed tomographic angiography (P<0.001). CONCLU-
SIONS: In a multicenter European population of patients with stable chest pain and low prevalence
of CAD, coronary computed tomographic angiography is more accurate than noninvasive functional
testing for detecting significant CAD defined invasively. CLINICAL TRIAL REGISTRATION URL:
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1Background—The choice of imaging techniques in patients with suspected coronary artery disease (CAD) varies between 
countries, regions, and hospitals. This prospective, multicenter, comparative effectiveness study was designed to assess 
the relative accuracy of commonly used imaging techniques for identifying patients with significant CAD.
Methods and Results—A total of 475 patients with stable chest pain and intermediate likelihood of CAD underwent coronary 
computed tomographic angiography and stress myocardial perfusion imaging by single photon emission computed 
tomography or positron emission tomography, and ventricular wall motion imaging by stress echocardiography or cardiac 
magnetic resonance. If ≥1 test was abnormal, patients underwent invasive coronary angiography. Significant CAD was 
defined by invasive coronary angiography as >50% stenosis of the left main stem, >70% stenosis in a major coronary 
vessel, or 30% to 70% stenosis with fractional flow reserve ≤0.8. Significant CAD was present in 29% of patients. In a 
patient-based analysis, coronary computed tomographic angiography had the highest diagnostic accuracy, the area under 
the receiver operating characteristics curve being 0.91 (95% confidence interval, 0.88–0.94), sensitivity being 91%, 
and specificity being 92%. Myocardial perfusion imaging had good diagnostic accuracy (area under the curve, 0.74; 
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confidence interval, 0.69–0.78), sensitivity 74%, and specificity 73%. Wall motion imaging had similar accuracy (area 
under the curve, 0.70; confidence interval, 0.65–0.75) but lower sensitivity (49%, P<0.001) and higher specificity (92%, 
P<0.001). The diagnostic accuracy of myocardial perfusion imaging and wall motion imaging were lower than that of 
coronary computed tomographic angiography (P<0.001).
Conclusions—In a multicenter European population of patients with stable chest pain and low prevalence of CAD, coronary 
computed tomographic angiography is more accurate than noninvasive functional testing for detecting significant CAD 
defined invasively.
Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT00979199.   
(Circ Cardiovasc Imaging. 2015;8:e002179. DOI: 10.1161/CIRCIMAGING.114.002179.)
Key Words: coronary artery disease ◼ coronary computed tomography angiography  
◼ echocardiography ◼ magnetic resonance imaging ◼ myocardial perfusion imaging  
◼ positron emission tomography ◼ single photon computed emission tomography
According to international guidelines, patients with stable chest pain and an intermediate likelihood of underlying 
coronary artery disease (CAD) should undergo initial exercise 
ECG or stress coronary functional imaging.1,2 The European 
guidelines favor imaging. Coronary computed tomography 
angiography (CCTA) is considered a reasonable alternative 
in low-likelihood patients. After diagnosis, failure of medical 
therapy to control symptoms or findings suggesting a high risk 
of coronary events justify invasive investigation as a prelude 
to possible intervention.2,3 Initial diagnostic invasive coronary 
angiography (ICA) in patients with stable CAD is not rec-
ommended, although in current practice as many as 30% of 
patients undergo ICA with no symptoms (including no angina), 
16% of patients undergo ICA without noninvasive testing, and 
an additional 15% undergo ICA even after normal noninvasive 
testing.4 Possibly as a consequence, 62% of stable patients 
without known CAD who undergo elective coronary angiog-
raphy in the United States and 42% of patients in Europe have 
no significant stenoses.4,5 Conversely, noninvasive testing does 
not always guide clinical management because 27% of patients 
with high-risk imaging results do not undergo ICA.6
See Clinical Perspective 
See Editorial by Douglas and Daubert
The choice of imaging technique varies between countries, 
regions, and hospitals, partly because of local expertise and 
customs and partly because guidelines do not specify a pre-
ferred technique. Among the noninvasive tests that are able to 
detect CAD, CCTA assesses coronary anatomy, whereas the 
others assess coronary function either from stress myocardial 
perfusion imaging (MPI) as single photon computed emission 
tomography (SPECT), positron emission tomography (PET), 
or cardiac magnetic resonance (CMR) or from stress myo-
cardial wall motion imaging (WMI) as echocardiography or 
CMR. Previous studies have compared the diagnostic accu-
racy of some of these technologies,7–10 but there is no large 
multicenter study comparing MPI, WMI, and CCTA. With 
this in mind, the Evaluation of Integrated Cardiac Imaging for 
the Detection and Characterization of Ischemic Heart Disease 
(EVINCI) study was designed to compare the diagnostic 
accuracy of noninvasive anatomic and functional imaging in 
identifying patients with significant CAD defined by ICA.
Methods
Study Design
Patients were enrolled prospectively from 14 European centers between 
March 23, 2009, and June15, 2012. Ethical approval was provided by 
each participating center, and all subjects gave written informed consent. 
The data were managed by the coordinating center and statistical analysis 
conducted by a dedicated partner. The study was funded under the 2009 
FPVII project of the European Commission. Additional industry support 
consisted of unrestricted grants and equipment, but the companies had 
no role in study design, analysis, interpretation, or reporting. The study 
protocol is available at http://www.clinicaltrials.gov (NCT00979199).
Study Population and Investigation
Consecutive patients were considered for recruitment based on pos-
sible symptoms of stable CAD. Chest pain or discomfort was defined 
as typical angina if substernal, provoked by exertion or emotional stress 
and relieved by rest or nitrates, as atypical angina if satisfying 2 of the 
criteria, and as nonanginal if satisfying 1 or none.11 Exertional dyspnea 
and fatigue suspected to be angina equivalents were classified as atypi-
cal angina. Patients with an interpretable resting ECG who were able to 
exercise underwent exercise electrocardiography (which was not man-
datory). Patients with an intermediate probability of CAD (20%–90%) 
based on age, sex, symptoms, and exercise ECG when available were 
invited to participate.11 Patients with acute coronary syndrome, known 
CAD, left ventricular ejection fraction <35%, more than moderate 
valve disease, and cardiomyopathy were excluded (see Methods in the 
Data Supplement for the full list of inclusion and exclusion criteria).
Patients underwent a study of coronary anatomy by CCTA and 
≥1 functional imaging test (Figure 1). Functional imaging included 
MPI by either SPECT or PET and ventricular WMI by either stress 
echocardiography or CMR. In most of the patients, imaging tests 
were performed within 1 month of enrolment and in any case within 3 
months. If ≥1 noninvasive anatomic or functional study was abnormal, 
patients underwent ICA. If both studies were normal, patients did not 
undergo additional investigations. Further clinical management was 
at the discretion of the local supervising clinician. Radiation exposure 
was estimated for CCTA, SPECT, PET, and ICA. Adverse events and 
revascularization procedures within 30 days of ICA were recorded.
Image Acquisition and Analysis
Standard acquisition and analysis protocols were agreed on for each 
technique covering patient preparation, cardiovascular stress, admin-
istration of radiopharmaceutical or contrast medium, image acquisi-
tion and quality control, image processing and interpretation. These 
procedures were based on available international guidelines.12–15 
Image analysis and reporting was performed independently at each 
recruiting center and at a core laboratory dedicated to each technique.
At local analysis, the observers were aware of the clinical data; 
ICA operators had full access to the clinical information and tests. 
Study quality was rated as suboptimal, good, or excellent.
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The primary end point was a significant stenosis in ≥1 major coronary 
artery (left main, left anterior descending, left circumflex, and right) at 
ICA, defined as >50% reduction in lumen diameter in the left main stem 
or >70% elsewhere or between 30% and 70% with a fractional flow re-
serve (FFR) ≤0.80. The primary end point was set to negative in patients 
with all negative noninvasive tests, who did not undergo ICA.
CCTA was defined as abnormal if ≥1 major coronary artery had 
a diameter stenosis >50%. For MPI, perfusion in each of 17 seg-
ments was classified as normal, mild reduction, moderate reduction, 
severe reduction, or absent perfusion, and the segmental scores were 
summed for the stress and rest images. An inducible perfusion abnor-
mality was defined as a summed segmental difference score between 
stress and rest images ≥2, either from a score ≥1 in ≥2 contiguous 
segments, or ≥2 in ≥1 segment. Scarring was defined similarly from 
the summed segmental rest score. For WMI, segmental myocardial 
wall motion was scored at rest and during stress as normal, hypoki-
netic, akinetic, or dyskinetic. Inducible ischemia was defined as an 
increase in segmental wall motion score ≥1 from rest to stress in ≥2 
contiguous segments. Scarring was defined similarly from the resting 
wall motion score.
Core laboratory analysis was performed in the patients who com-
pleted the protocol and for whom noninvasive and invasive images 
were made available and were judged as interpretable. The observers 
were blinded to the clinical data and to any other test results. Image 
quality was rated using the same 3-point scale as the recruiting cen-
ters, and abnormality was defined in the same manner. Core labora-
tory images were compared with core laboratory quantitative ICA 
without FFR using >50% diameter stenosis as abnormal.
Definitions and Statistical Analysis
Sample size was calculated to detect at least a 7-point difference in di-
agnostic accuracy of the different imaging techniques, assuming true 
values for area under a single point receiver-operating-characteristic 
curves in the range 0.80 to 0.90 and correlations between curves 0.6. 
Foreseeing a 50% prevalence of disease, ≥300 patients were required 
to achieve 80% power with P<0.05 at a 2-sided test. To achieve these 
numbers, SPECT and PET were analyzed together as MPI and echo-
cardiography and CMR together as WMI.
Continuous variables were expressed as mean (±SD) or median with 
25th and 75th percentiles. Categorical variables were expressed as 
numbers and percentages. The diagnostic performance of noninvasive 
imaging to detect CAD was calculated by patient rather than by coro-
nary artery. The accuracy of each technique was expressed as the area 
under a single point receiver-operating-characteristic curve using the 
trapezoidal rule,16 which is equivalent to the average of the sensitivity 
and specificity. Sensitivity, specificity, positive, and negative predictive 
values were calculated with 95% confidence intervals obtained by a 
bootstrap method using 100 000 replicates. Sensitivity and specificity 
were compared using tests for 2 proportions. To account for possible 
selection bias caused by the referral criteria to ICA, bias corrected 
sensitivity and specificity were also estimated.17,18 Based on the Bayes 
theorem, the method used provides estimates of sensitivity and speci-
ficity in the overall population adjusting for the empirical probability 
of verification by ICA. P≤0.05 was considered significant. Calculations 
were made using STATA v10 and pROC in R v2.15.2.
Results
A total of 697 patients were initially enrolled, 78 (11%) 
subsequently withdrew from the study and 144 (21%) were 
excluded for protocol violation (Figure 2). Of the excluded 
patients, 54 underwent ICA but did not undergo both ana-
tomic and functional noninvasive imaging, 45 did not undergo 
ICA despite an abnormal functional test, 7 despite abnormal 
CCTA and 4 despite both abnormal tests. Finally, 34 patients 
were excluded because they did not undergo FFR measure-
ment despite intermediate coronary stenoses by ICA. Thus, 
475 patients (68%) completed the entire protocol and were 
included in the analysis. The estimated pretest probability of 
CAD was 65% (interquartile range, 33%–75%). The clinical 
Population
Patients with anginal-like chest pain or equivalent symptoms
Clinical evaluation and enrolment
Intermediate (20-90%) probability of CAD
Fulfilling inclusion/exclusion criteria
Signed informed consent
Treatment
according to clinical judgment
Non invasive cardiac imaging
Non-invasive anatomical imaging by CCTA
+
Non-invasive functional imaging by
Stress SPECT or PET and/or 
Stress Echocardiography or CMR
Invasive Coronary Angiography
+
FFR if 30-70% stenosis
All non invasive imaging negative
Short-term Follow-up
At least one non invasive imaging positive
Figure 1. Study design. CAD indicates coronary 
artery disease; CCTA, coronary computed tomog-
raphy angiography; CMR, cardiac magnetic reso-
nance; FFR, fractional flow reserve; PET, positron 
emission tomography; SPECT, single photon com-
puted emission tomography.
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and angiographic characteristics of these patients are shown 
in Table 1.
Each of these patients underwent both a noninvasive study 
of coronary anatomy by CCTA and ≥1 noninvasive stress cor-
onary functional test. A total of 389 patients underwent MPI 
(293 SPECT and 96 PET), 346 patients underwent WMI (261 
echocardiography and 85 CMR), and 260 patients underwent 
both MPI and WMI. ICA was performed in 307 patients who 
had ≥1 abnormal noninvasive test. FFR was measured in 45 
patients with 30% to 70% coronary stenoses. The primary 
end point of significant CAD was detected in 140 patients 
(29%). Within 30 days after ICA, 97 patients (20%), cor-
responding to 69% of patients with significant coronary 
stenoses, underwent myocardial revascularization by percu-
taneous coronary intervention (17% of patients) or coronary 
artery bypass grafting (3% of patients). Revascularization 
was performed in 54% of patients with positive CCTA, 37% 
of patients with positive MPI (33% SPECT and 60% PET), 
and 50% of patients with positive WMI (48% Echo and 56% 
MRI).
No serious adverse events were reported during nonin-
vasive imaging, but 4 patients had severe chest pain during 
CCTA. One patient had a stroke during percutaneous coronary 
intervention. Mean radiation exposure was 11.2±8.1 mSv for 
CCTA, 10.0±2.7 mSv for SPECT, 1.7±1.5 mSv for PET, and 
12.8±14.8 mSv for ICA, including revascularization when 
performed.
Accuracy of Noninvasive Imaging for Detecting 
CAD, Local Analysis
Table 2 shows the diagnostic accuracy of the imaging tech-
niques using local analysis for the detection of significant 
CAD defined by ICA. CCTA was more accurate than MPI 
and WMI (P<0.001). The functional techniques had similar 
accuracy, although WMI had lower sensitivity with higher 
specificity (Figure 3). The relative accuracy of noninvasive 
imaging did not change substantially, selecting the patient 
with an intermediate probability of CAD calculated accord-
ing to a more recent prediction model5 (Table I in the Data 
Supplement). The relative accuracy was also unchanged, 
limiting the analysis to subgroups, such as male or female 
patients, patients >65 year, or patients with a pretest likeli-
hood of ≥50%. In patients referring typical angina, the accu-
racy of CCTA and MPI was unchanged, whereas that of 
WMI increased being not significantly different from that of 
CCTA (Table II in the Data Supplement). Finally, the relative 
accuracy was unchanged considering as end point a merely 
angiographic variable: ie, a >50% coronary stenosis at ICA 
(Table III in the Data Supplement). Wall motion abnormalities 
were present at rest in 4% of echocardiographic and 8% of 
CMR studies. The relative accuracies of the techniques did not 
change significantly when restricting the analysis to patients 
with only stress-induced abnormalities (Table 3). After cor-
rection for verification bias, sensitivity of CCTA, MPI, and 
WMI was lower than that before correction, whereas specific-
ity and comparative diagnostic performance were unchanged 
(Table 4).
Accuracy of Noninvasive Imaging for Detecting 
CAD, Core Laboratory Analysis
The clinical characteristics of the patients included in the core 
laboratory analysis (350 for CCTA, 219 for SPECT, 59 for 
PET, 189 for echocardiography, and 82 for CMR) did not sig-
nificantly differ from the whole population (Table IV in the 
697 patients enrolled
78 drop outs
619 had imaging evaluation 
144 protocol violations:
- 54 did not undergo both CCTA and stress imaging
- 56 did not undergo ICA despite a positive non-invasive imaging
- 34 did not undergo FFR despite intermediate coronary stenoses at ICA
475 completed the protocol 
WMI in 346 patients
(261 ECHO and 85 CMR)
CCTA in 475 patients
MPI in 389 patients 
(293 SPECT and 96 PET)
ICA in 307 patients with
positive non invasive imaging
FFR in 45 patients with
intermediate stenoses
Figure 2. Enrolment and diagnostic procedures. 
CCTA indicates coronary computed tomography 
angiography; CMR, cardiac magnetic resonance; 
FFR, fractional flow reserve; ICA, invasive coronary 
angiography; MPI, myocardial perfusion imaging; 
PET, positron emission tomography; SPECT, single 
photon computed emission tomography; and WMI, 
wall motion imaging.
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Data Supplement). Stress response was considered submaxi-
mal in 41% of the echocardiographic studies and in 7% of 
the CMR studies. Anti-anginal treatment was not withdrawn 
in 23% of the echocardiographic studies. Image quality was 
judged as good or excellent in 40% of CCTA, 56% of SPECT, 
49% of PET, 55% of echocardiographic, and in 84% of CMR 
studies.
The accuracy of each technique was substantially unchanged 
with local or core laboratory analysis, although the sensitivity 
of CCTA, SPECT, and echocardiography tended to be lower 
at core laboratory than at local analysis (Table 5). When only 
the patients in whom the image quality was rated good-to-
excellent were included in the analysis, the relative accuracy 
of the different imaging modalities did not change, although 
the sensitivity of CCTA and SPECT were higher at 81% for 
both without loss of specificity (Table 5).
Discussion
In this prospective, pragmatic, multicenter comparative effec-
tiveness study of patients with stable chest symptoms sugges-
tive of CAD, the presence of significant stenoses at ICA was 
diagnosed more accurately by CCTA than by functional imag-
ing. This study has several unique features: (1) CCTA and 
several different functional imaging techniques were com-
pared prospectively using ICA as the diagnostic end-point; 
(2) patients had intermediate likelihood of CAD and were 
recruited from routine practice in 14 European centers with 
current techniques and equipment; and (3) images were ana-
lyzed both locally, according to common clinical practice, and 
in dedicated core laboratories to ensure uniformity of interpre-
tation. For the above reasons, we think that our results closely 
reflect contemporary real-world practice in Europe.
The greater diagnostic accuracy of an anatomic test, CCTA, 
over functional imaging is most likely the result of the end point 
used, which was primarily anatomic. Ninety-one percent of 
patients with significant CAD had stenoses >70%, and only 9% 
had intermediate lesions with reduced FFR. This favored CCTA 
because 2 anatomic techniques are likely to agree more than 
when a functional technique is compared with an anatomic one. 
The findings might have differed if more patients with interme-
diate stenoses would have been submitted to FFR measurement 
or if a harder end point, such as clinical outcome or appropri-
ateness of coronary revascularization, would have been used. 
Coronary function assessed as inducible perfusion abnormali-
ties by SPECT or wall motion abnormalities by echocardiog-
raphy is a stronger predictor of clinical outcome than coronary 
anatomy assessed by ICA.19,20 For this reason, the most recent 
guidance regarding the assessment of stable CAD is that the 
presence of inducible ischemia should guide the need for revas-
cularization, not just the degree of coronary stenosis.2,3
An important feature of this study is that the prevalence of 
CAD was 29%. CCTA has a high negative predictive value 
and would perform better at low prevalence of disease. The 
findings therefore support the role of CCTA in patients with 
lower pretest probability of CAD, in agreement with the recent 
ESC and NICE Guidelines.2,21 Similar low prevalence has 
been reported in other studies.5 In a large registry of symptom-
atic and asymptomatic patients who underwent ICA between 
2004 and 2008, the prevalence of CAD was 38%, lower in 
Table 1.Clinical and Angiographic Characteristics Shown as 
mean±SD, Median (Interquartile Range), or Number (%)
Study Patients (n=475)
Demographics
  Age, y 60±9
  Males 291 (61%)
Cardiovascular risk factors
  Family history of CAD 160 (34%)
  Diabetes mellitus 115 (24%)
  Hypertension 290 (61%)
  Hypercholesterolemia 267 (56%)
  Obesity 112 (24%)
  Smoking within the last year 120 (25%)
Symptoms
  Typical angina 121 (25%)
  Atypical angina 288 (61%)
  Non-anginal chest pain 66 (14%)
ECG
  Normal 372 (78%)
  Left bundle branch block 12 (3%)
  Left ventricular hypertrophy 5 (1%)
  Other abnormalities 86 (18%)
Left ventricular ejection fraction
  ≥50% 451 (95%)
  35–50% 24 (5%)
Exercise ECG
  Bicycle 267 (56%)
  Treadmill 114 (24%)
  Not done 94 (20%)
  ≥0.15 mV ST depression 71 (19%)
  Probability of CAD 65% (33–75)
Coronary calcium score (Agatston)
  0 123 (26%)
  1–99 107 (22%)
  100–399 85 (18%)
  ≥400 83 (18%)
  Not done 77 (16%)
Invasive coronary angiography
  Not done 168 (35%)
  Normal vessels 112 (24%)
  Nonobstructive disease 55 (12%)
  Single vessel disease 99 (21%)
  Double vessel disease 25 (5%)
  Triple vessel disease 10 (2%)
  Left main stem disease 6 (1%)
Revascularization within 30 days
  Percutaneous coronary intervention 85 (17%)
  Coronary artery bypass graft surgery 13 (3%)
CAD indicates coronary artery disease.
 at Universitaet Zuerich on February 23, 2016http://circimaging.ahajournals.org/Downloaded from 
6  Neglia et al  Noninvasive Imaging to Detect CAD
patients who underwent CCTA alone.4 Among patients who 
were undergoing CCTA within 3 months of stress testing in 
the ACIC consortium, the prevalence of patients with >50% 
stenosis was 19%.22
The reported accuracy of CCTA is variable, although 
generally lower than in this study.23–25 In CORE-64, it was 
similar to this study (area under the curve 0.93 versus 0.91), 
although the positive predictive value was higher (91% ver-
sus 83%) and negative predictive value lower (83% versus 
91%).23 These differences are likely to be the result of the 
higher prevalence of CAD (56%) in CORE-64 because with 
increasing prevalence, positive predictive value will increase, 
whereas negative predictive value will decrease. Other differ-
ences that explain the variation may be scanner technology, 
sample size, and the inclusion of patients with significant 
coronary calcification.
The accuracy of MPI in this study was comparable to that 
in others, even if at the lower end of the range.26 Conversely, 
the accuracy of WMI was lower than previously reported 
for both echocardiography and CMR.12,27 This could be the 
result of several factors. Sub-maximal stress was reported in 
41% of echocardiographic examinations, and 23% of patients 
remained on medical therapy, both of which will have reduced 
sensitivity.28 Additional information, such as Doppler coro-
nary flow reserve by echocardiography, myocardial perfusion 
for CMR, and quantitative myocardial perfusion for PET, 
could have improved the performance of functional imag-
ing.29–33 Lack of clinical information in the core laboratories 
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Figure 3. Sensitivity and specificity of noninvasive imaging 
techniques. 
CCTA indicates coronary computed tomography angiography; CMR, cardiac 
magnetic resonance; ECHO, echocardiography; PET, positron emission tomog-
raphy; and SPECT, single-photon computed emission tomography.
Table 3.Diagnostic Accuracy of Imaging Techniques for the Detection of Significant Coronary Stenoses at ICA Using Local Analysis 
and Inducible Ischemia as the Only Positivity Criterion for Stress Imaging
Technique N Accuracy, % (95% CI) Sensitivity, % (95% CI) Specificity, % (95% CI) PPV, % (95% CI) NPV, % (95% CI)
CCTA 475 91 (88–94) 91 (86–95) 92 (89–95) 83 (76–88) 96 (93–98)
MPI 389 73* (68–78) 69* (61–78) 76* (71–81) 57 (48–65) 85 (79–89)
  SPECT 293 70 (64–75) 68 (59–77) 71 (64–77) 55 (46–64) 81 (74–87)
  PET 96 83 (73–92) 76 (57–91) 89 (81–96) 67 (45–84) 93 (85–98)
WMI 348 67* (62–72) 38*† (29–49) 95† (92–97) 75 (60–86) 80 (74–84)
  Echocardiography 261 66 (60–72) 39 (28–51) 93 (90–96) 68 (51–81) 81 (75–86)
  CMR 87 68 (60–77) 37 (20–53) 100 100 (62–100) 75 (64–84)
CCTA indicates computed tomography coronary angiography; CI, confidence interval; CMR, cardiac magnetic resonance; ICA, invasive coronary angiography; MPI, 
myocardial perfusion imaging; NPV, negative predictive value; PET, positron emission tomography; PPV, positive predictive value; SPECT, single photon computed 
emission tomography; and WMI, wall motion imaging.
*P<0.001 MPI or WMI vs CCTA.
†P<0.001 MPI vs WMI.
Table 2.Diagnostic Accuracy of Imaging Techniques for the 
Detection of Significant Coronary Stenoses at ICA Using Local 
Analysis
Technique N
Accuracy, 
%  
(95% CI)
Sensitivity, 
%  
(95% CI)
Specificity, 
%  
(95% CI)
PPV,  
%  
(95% CI)
NPV, 
%  
(95% CI)
CCTA 475 91  
(88–94)
91  
(86–95)
92  
(89–95)
83  
(76–88)
96  
(93–98)
MPI 389 74* 
(69–78)
74† 
(66–82)
73* 
(68–78)
56  
(48–63)
86  
(81–91)
  SPECT 293 70  
(64–75)
73  
(64–81)
67  
(60–74)
53  
(45–62)
83  
(76–88)
  PET 96 85  
(76–94)
81  
(62–95)
89  
(81–96)
68  
(46–85)
94  
(86–98)
WMI 346 70* 
(65–75)
49*‡ 
(38–59)
92‡ 
(88–95)
69  
(57–80)
82  
(77–86)
  Echocardio- 
 graphy
261 68  
(61–74)
45  
(33–57)
90  
(86-94)
62  
(47–75)
82  
(76–87)
  CMR 85 77  
(67–89)
57  
(39–75)
97  
(91–100)
89  
(65–99)
82  
(71–90)
CCTA indicates computed tomography coronary angiography; CI, confidence 
interval; CMR, cardiac magnetic resonance; ICA, invasive coronary angiography; 
MPI, myocardial perfusion imaging; NPV, negative predictive value; PET, 
positron emission tomography; PPV, positive predictive value; SPECT, single 
photon computed emission tomography; and WMI, wall motion imaging.
*P<0.001 MPI or WMI vs CCTA.
†P=0.001 MPI vs CCTA.
‡P<0.001 MPI vs WMI.
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could also explain the lower sensitivity in the core laboratories 
than in the centers, which was most evident for echocardiogra-
phy, SPECT, and CCTA.
Current guidelines do not indicate which functional imag-
ing technique should be favored, but it is recommended that 
the choice should consider local availability and expertise, the 
Table 4.Sensitivity and Specificity of Imaging Techniques for the Detection of Significant Coronary Stenoses at ICA 
Using Local Analysis, Without and With Correction for Verification Bias
Techinique
CCTA (N=475) MPI (N=389) WMI (N=346) SPECT (N=293) PET (N=96) ECHO (N=261) CMR (N=85)
Sensitivity, % (95% 
CI)
91  
(86–95)
74*†  
(66–82)
49‡  
(38–59)
73  
(64–81)
81  
(62–95)
45  
(33–57)
57  
(39–75)
Sensitivity after 
correction for 
verification bias, % 
(95% CI)
82  
(74–91)
59†‡  
(50–69)
36‡  
(27–45)
53  
(43–63)
74  
(53–95)
32  
(22–43)
46  
(27–64)
P value 0.008 0.001 0.011 <0.001 0.622 0.028 0.256
Specificity, % (95% 
CI)
92  
(89–95)
73†‡  
(68–78)
92  
(88–95)
67  
(60–74)
89  
(81–96)
90  
(86–94)
97  
(91–100)
Specificity after 
correction for 
verification bias, % 
(95% CI)
92  
(89–95)
70†‡  
(63–76)
90  
(86–94)
59  
(50–68)
89  
(82–96)
88  
(84–94)
96  
(90–100)
P value 0.920 0.232 0.524 0.023 0.891 0.572 1
CCTA indicates computed coronary tomography angiography; CI, confidence interval; CMR, cardiac magnetic resonance; ICA, invasive coronary 
angiography; MPI, myocardial perfusion imaging; PET, positron emission tomography; SPECT, single photon computed emission tomography; and 
WMI, wall motion imaging. P value from binomial probability test for comparison between corrected and uncorrected values.
*P=0.001 MPI vs CCTA.
†P<0.001 MPI vs WMI.
‡P<0.001 MPI or WMI vs CCTA.
Table 5.Diagnostic Accuracy of Imaging Techniques for the Detection of Significant Coronary Stenoses at 
ICA Using Core Laboratory Analysis
Technique N
Accuracy, %  
(95% CI)
Sensitivity, %  
(95% CI)
Specificity, %  
(95% CI)
PPV, %  
(95% CI)
NPV, %  
(95% CI)
CCTA
  All images 350 82 (77–86) 71 (62–81) 92 (88–95) 77 (67–85) 89 (85–93)
  Good or excellent 
quality
140 86 (77–94) 81 (65–96) 91 (86–96) 68 (49–83) 95 (90–98)
SPECT
  All images 219 74 (68–80) 58 (46–70) 90 (85–95) 73 (59–84) 82 (76–88)
  Good or excellent 
quality
123 84 (76–90) 81 (69–93) 86 (79–94) 76 (60–87) 90 (81–95)
PET
  All images 59 81 (69–92) 80 (60–100) 82 (71–93) 60 (36–81) 92 (79–98)
  Good or excellent 
quality
29 80 (58–96) 80 (40–100) 79 (63–96) 44 (14–79) 95 (75–100)
Echocardiography
  All images 189 60 (54–66) 24 (12–36) 95 (92–99) 63 (38–84) 78 (71–84)
  Good or excellent 
quality
105 62 (54–71) 27 (12–46) 98 (94–100) 78 (40–97) 80 (71–88)
CMR
  All images 82 80 (67–87) 54 (35–73) 100 100 (68–100) 82 (71–91)
  Good or excellent 
quality
69 75 (65–85) 50 (30–70) 100 100 (59–100) 83 (71–92)
CCTA indicates computed tomography coronary angiography; CI, confidence interval; CMR, cardiac magnetic resonance; ICA, 
invasive coronary angiography; MPI, myocardial perfusion imaging; NPV, negative predictive value; PET, positron emission tomography; 
PPV, positive predictive value; and SPECT, single photon computed emission tomography.
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cost, and the risks of contrast agents and radiation exposure.34 
The health-economic analysis of the EVINCI study will be 
performed separately.
This study has several limitations. Sample size calculations 
assumed a 50% prevalence of obstructive CAD, true values for 
area under the curves in the range 0.80 to 0.90, and correlations 
between curves being 0.6 to detect a difference of ≥7% in the 
accuracy of CCTA and functional imaging. Some of the above 
assumptions were not met, and the difference in accuracy actu-
ally was higher (range 17–21%). The study power, recalcu-
lated according to the observed values, was >90% in pairwise 
comparisons of CCTA, MPI, and WMI, but was inadequate for 
comparing individual functional imaging modalities.
The enrolled patients were selected more often from stress 
imaging laboratories and cardiology divisions than from the 
emergency rooms; moreover, patients with >90% likelihood 
of CAD were excluded. Thus, the study cohort could not be 
representative of the higher risk patients referred for imaging 
testing.
To have had both a CCTA and a functional test is not com-
mon practice in most centers and could have favored protocol 
violations. However, of the 144 patients excluded from the 
analysis, 54 did not undergo any noninvasive test, 45 did not 
undergo ICA despite positive stress imaging test, 7 despite posi-
tive CCTA, and 4 despite both positive tests. Thus, it is unlikely 
that protocol violations could have modified the results in favor 
of CCTA. Similarly, 168 patients with normal CCTA and func-
tional studies did not undergo ICA according to the protocol. 
To account for the potential of a selection bias consequent to 
the number of patient excluded, a sensitivity analysis was per-
formed in the patients in whom imaging data were available, 
despite some protocol violation. No differences for any mea-
surement of performance were observed in comparison with 
the primary analysis (Table V in the Data Supplement).
Setting the reference standard to negative in subjects with 
all negative noninvasive testing could have introduced a veri-
fication bias. After correction for verification bias, sensitivity 
of imaging modalities significantly decreased, whereas speci-
ficity and the relative performance were unchanged (Table 4).
To privilege local facilities and expertise, the decision 
regarding which patients underwent stress SPECT, PET, echo-
cardiography, or CMR was not defined in the protocol but left 
to the enrolling centers. However, no significant difference 
in the prevalence of obstructive CAD was present in patients 
investigated by CCTA, MPI, and WMI.
Although acquisition and analysis protocols were agreed 
on for each technique before data acquisition, differences 
in imaging protocols between the different centers still per-
sisted. This could have been one of the causes of the wide 
range in radiation exposure registered for some exams, such 
as CCTA.
For stress CMR, a significant number of laboratories now 
use contrast-enhanced MPI, deemed to provide superior accu-
racy as opposed to WMI. However, this standard was not 
so widely accepted when the EVINCI study was designed. 
Quantitative coronary angiography was not used at enrolling 
centers, but only at the ICA core laboratory. Although the core 
laboratory patients did not differ from the whole population, 
core laboratory analysis was not performed in each patient. 
Finally, a significant stenosis was defined as luminal narrow-
ing >70%, and only stenoses between 30% and 70% were fur-
ther investigated by FFR. After defining this study protocol, 
the FAME II study showed that only 72% of stenoses between 
70% and 90% in women and 82% in men had abnormal FFR.35
 
Almost half of the patients with intermediate stenoses did not 
undergo FFR and were thus excluded from the study, confirm-
ing that FFR did not still gain common clinical practice.
Conclusions
In a multicenter European population of patients with stable 
chest pain and low prevalence of disease, CCTA is the most 
accurate imaging technique for detecting significant CAD 
defined by ICA. Functional imaging based on myocardial per-
fusion is more sensitive but less specific than functional imag-
ing based on ventricular wall motion.
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CLINICAL PERSPECTIVE
The choice of imaging techniques in patients with suspected coronary artery disease (CAD) varies between countries, 
regions, and hospitals. The Evaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischemic 
Heart Disease (EVINCI) Study was designed to compare the diagnostic accuracy of noninvasive anatomic and functional 
imaging in identifying patients with obstructive CAD, defined by invasive coronary angiography. The EVINCI population 
consisted of patients with stable chest pain or equivalent symptoms, currently referred for cardiac imaging. The prevalence 
of obstructive CAD at invasive coronary angiography was <30%. The results of the study show that coronary computed 
tomography angiography is the most accurate imaging technique to detect obstructive CAD in this population. Functional 
imaging based on myocardial perfusion is more sensitive but less specific than functional imaging based on ventricular wall 
motion. These findings support the role of coronary computed tomography angiography in patients with low-to-intermediate 
pretest probability of CAD in agreement with the recent ESC and NICE Guidelines.
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SUPPLEMENTAL METHODS 
Study inclusion and exclusion criteria  
 
Inclusion criteria 
 Stable angina-like chest pain (typical, atypical or non-anginal) 
 Dyspnea and fatigue on effort suspected as anginal equivalent 
 
Exclusion criteria 
 Age < 30 or > 75 years 
 Low (≤ 20%) or high (≥ 90%) probability of coronary artery disease 
 Pregnancy (suspected or ascertained) 
 Acute coronary syndrome, defined by at least one of the following criteria: 
 Prolonged (> 20 minutes) chest pain 
 De novo or accelerated angina 
 Recent ST-T segment or T wave changes of ischemic nature 
 Elevated serum cardiac markers of necrosis 
 Hemodynamic or electrical instability 
 Acute myocardial infarction with or without ST segment elevation 
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 Known diagnosis of coronary artery disease, including 
 Previously known myocardial infarction 
 Previous percutaneous coronary interventions 
 Previous coronary artery bypass graft surgery 
 Left ventricular dysfunction (ejection fraction < 35% by echocardiography or other method) 
 Persistent/permanent atrial fibrillation or advanced atrioventricular block 
 Asthma or chronic treatment with aminophilline 
 Recent (< 6 months) cerebral ischemic attack 
 Active cancer 
 Severe hypertension  
 Cardiomyopathy (e.g., dilated cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic right ventricular dysplasia, amyloidosis) 
 Inability to provide  informed consent 
 Congenital heart disease 
 Known significant carotid stenosis or vascular aneurisms 
 Significant (≥ moderate) valvular disease 
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List of the study centres (Recruitment centers and Core Labs): 
- APHP, Groupe Hospitalier Bichat-Claude Bernard, Département Hospitalo-Universitaire FIRE and Université Paris Diderot, Paris, France  
- Azienda Ospedaliero Universitaria Careggi, Firenze, Italy  
- Centre for Advanced Cardiovascular Imaging, NIHR Cardiovascular Biomedical Research Unit at Barts, William Harvey Research Institute, Barts and The London 
School of Medicine, Queen Mary University of London, London, United Kingdom  
- Fondazione Toscana G. Monasterio, Pisa, Italy  
- Imperial College London, United Kingdom  
- Institut Catala de la Salut, Barcelona, Spain  
- Institute of Cardiology, Warsaw, Poland  
- Institute of Clinical Physiology, National Research Council, Pisa, Italy  
- Kliniken des Landkreises Göppingen, Göppingen, Germany  
- Klinikum rechts der Isar der Technischen Universitat Munchen, Munchen, Germany  
- Leiden University Medical Center, Leiden, The Netherlands  
- Ospedale della Versilia, Lido di Camaiore, Italy  
- Università di Genova, Genoa, Italy  
- Università di Napoli Federico II, Naples, Italy  
- University Hospital Clinico San Carlos, Madrid, Spain  
- University Hospital Zurich, Zurich, Switzerland 
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- University of Turku and Turku University Hospital, Turku, Finland  
 
Number of patients enrolled (included in the analysis) per center 
- University of Turku and Turku University Hospital, Turku, Finland: 96 (71) patients  
- Institute of Cardiology, Warsaw, Poland: 44 (36) patients  
- Institut Catala de la Salut, Barcelona, Spain: 50 (44) patients  
- Fondazione Toscana G. Monasterio, Pisa, Italy: 118 (69) patients  
- Kliniken des Landkreises Göppingen, Göppingen, Germany: 44 (35) patients  
- Ospedale della Versilia, Lido di Camaiore, Italy: 35 (25) patients  
- Centre for Advanced Cardiovascular Imaging, NIHR Cardiovascular Biomedical Research Unit at Barts, William Harvey Research Institute, Barts and The London 
School of Medicine, Queen Mary University of London, London, United Kingdom: 45 (27) patients  
- APHP, Groupe Hospitalier Bichat-Claude Bernard, Département Hospitalo-Universitaire FIRE and Université Paris Diderot, Paris, France: 43 (28) patients  
- Azienda Ospedaliero Universitaria Careggi, Firenze, Italy: 20 (17) patients  
- Università di Genova, Genoa, Italy: 33 (18) patients  
- Università di Napoli Federico II, Naples, Italy: 69 (21) patients  
- University Hospital Clinico San Carlos, Madrid, Spain:  20 (17) patients  
- Klinikum rechts der Isar der Technischen Universitat Munchen, Munchen, Germany: 4 (0) patients  
- University Hospital Zurich, Zurich, Switzerland: 76 (67) patients 
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SUPPLEMENTAL TABLES 
Supplemental Table 1. Diagnostic accuracy of imaging techniques for the detection of significant coronary stenoses at ICA using local analysis and selecting the patients with an 
intermediate probability of CAD calculated according to a recently updated prediction model (Genders TS et al. Eur Heart J. 2011, Ref. 5) 
 
Measure of Accuracy Imaging Techniques 
  
CCTA 
(N = 449) 
MPI 
(N = 367) 
WMI 
(N = 326) 
SPECT 
(N = 282) 
PET 
(N = 85) 
ECHO 
(N = 247) 
CMR 
(N = 79) 
Positivity by test - no 150 155 66 131 24 48 18 
Positivity by ICA - no 137 118 95 99 19 67 28 
AUC (95% CI) 
0.91 
(0.88-0.94) 
0.74** 
(0.69-0.79) 
0.70** 
(0.65-0.75) 
0.70 
(0.65-0.76) 
0.86 
(0.76-0.94) 
0.67 
(0.61-0.74) 
0.77 
(0.67-0.86) 
False positive - no 26 67 20 59 8 18 2 
False negative - no 13 30 49 27 3 37 12 
Sensitivity, % (95% CI) 
91 
(85-95) 
75*# 
(67-82) 
48** 
(39-59) 
73 
(64-81) 
84 
(68-1) 
45 
(33-57) 
57 
(39-75) 
Specificity, % (95% CI) 
92 
(88-95) 
73**# 
(67-78) 
91 
(87-95) 
68 
(61-74) 
88 
(80-95) 
90 
(86-94) 
96 
(90-100) 
PPV, % (95% CI) 
83 
(76-88) 
57 
(49-65) 
70 
 (57-80) 
55 
(46-64) 
67 
(45-84) 
63 
(47-76) 
89 
(65-99) 
NPV, % (95% CI) 
96 
(93-98) 
86 
(80-90) 
81 
(76-86) 
82 
(75-88) 
95 
(86-99) 
81 
(75-87) 
80 
(68-89) 
 
CCTA = computed coronary tomography angiography; CI = confidence interval; CMR = cardiac magnetic resonance; MPI = myocardial perfusion imaging; PET = positron 
emission tomography; SPECT = single photon computed emission tomography; WMI = wall motion imaging. **P<0.001, *P=0.001 MPI or WMI vs CCTA; #P<0.001 MPI      
vs WMI 
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Supplemental Table 2. Diagnostic accuracy of imaging techniques for the detection of significant coronary stenoses at ICA using local analysis and selecting the patients by 
gender, age, probability of CAD by D&F, or symptoms.  
 
 
Subgroups N 
CAD 
prevalence, % 
Imaging 
Techniques 
AUC 
(95% CI) 
Sensitivity,  
% (95% CI) 
Specificity,  
% (95% CI) 
PPV, 
% (95% CI) 
NPV,  
% (95% CI) 
Male gender 291 37 
CCTA 0.92 (0.88-0.95) 92 (86-96) 92 (87-96) 87 95 
MPI 0.77 (0.71-0.82) 79 (70-86) 75 (67-81) 66 85 
WMI 0.69 (0.62-0.75) 49 (37-59) 89 (83-94) 73 74 
Female gender 184 17 
CCTA 0.90 (0.83-0.95) 87 (74-97) 92 (88-96) 69 97 
MPI 0.66 (0.56-0.76) 61 (43-79) 71 (63-79) 33 89 
WMI 0.71 (0.60-0.82) 48 (29-67) 95 (91-98) 59 92 
> 65 years 159 37 
CCTA 0.90 (0.85-0.95) 92 (83-98) 89 (83-95) 83 95 
MPI 0.74 (0.66-0.82) 72 (58-83) 77 (67-85) 66 81 
WMI 0.71 (0.63-0.79) 53 (38-67) 89 (81-96) 75 75 
Probability of 
CAD >50% 
324 34 
CCTA 0.92 (0.89-0.95) 92 (86-96) 93 (89-96) 87 96 
MPI 0.73 (0.67-0.78) 75 (66-83) 71 (64-77) 59 84 
WMI 0.72 (0.66-0.78) 51 (39-62) 93 (89-97) 78 80 
Typical angina 121 30 
CCTA 0.90 (0.84-0.96) 89 (78-97) 92 (86-96) 82 95 
MPI 0.75 (0.66-0.84) 80 (67-93) 70 (57-81) 60 86 
WMI 0.82 (0.72-0.91) 70 (52-85) 93 (86-99) 79 90 
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Supplemental Table 3. Diagnostic accuracy of imaging techniques for the detection of coronary stenoses  > 50% at ICA using local analysis 
Measure of Accuracy Imaging Techniques 
  
CCTA 
(N = 475) 
MPI 
(N = 389) 
WMI 
(N = 346) 
SPECT 
(N = 293) 
PET 
(N = 96) 
ECHO 
(N = 261) 
CMR 
(N = 85) 
Positivity by test - no 154 162 68 137 25 50 18 
Positivity by ICA - no 144 126 102 103 23 73 29 
AUC (95% CI) 
0.93 
(0.90-0.95) 
0.74** 
(0.70-0.79) 
0.69** 
(0.64-0.75) 
0.71 
(0.65-0.76) 
0.84 
(0.75-0.93) 
0.67 
(0.61-0.73) 
0.76 
(0.66-0.85) 
False positive - no 21 68 20 61 7 18 2 
False negative - no 11 32 54 27 5 41 13 
Sensitivity, % (95% CI) 
92 
(88-97) 
75**# 
(67-82) 
47** 
(37-57) 
74 
(65-82) 
78 
(61-96) 
44 
(33-55) 
55 
(38-72) 
Specificity, % (95% CI) 
94 
(89-95) 
74**# 
(68-78) 
92 
(88-95) 
68 
(61-74) 
90 
(84-96) 
90 
(86-94) 
96 
(91-100) 
PPV, % (95% CI) 
86 
(80-91) 
58 
(50-66) 
71 
(58-81) 
56 
(47-64) 
72 
(51-88) 
64 
(49-77) 
89 
(65-99) 
NPV, % (95% CI) 
97 
(94-98) 
86 
(81-90) 
81 
(75-85) 
83 
(76-88) 
93 
(84-98) 
81 
(75-86) 
81 
(69-89) 
 
CCTA = computed coronary tomography angiography; CI = confidence interval; CMR = cardiac magnetic resonance; MPI = myocardial perfusion imaging; PET = positron 
emission tomography; SPECT = single photon computed emission tomography; WMI = wall motion imaging. **P<0.001 MPI or WMI vs CCTA; #P<0.001 MPI vs WMI 
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Supplemental Table 4. Baseline clinical and angiographic characteristics of patients included in the centers or core lab analyses 
 
 Center patients (N=475) Corelab patients (N=350) 
Demographics   
Age―years 60±9 60±9 
Male sex―no. (%) 291 (61) 209(60) 
Cardiovascular risk factors   
Family history of premature CAD―no. (%) 160 (34) 115(33) 
Diabetes mellitus―no. (%) 115 (24) 78(22) 
Hypertension―no. (%) 290 (61) 208(59) 
Hypercholesterolemia―no. (%) 267 (56) 194(55) 
Obesity―no. (%) 112 (24) 277(79) 
Smoking within the last year―no. (%) 120 (25) 88(25) 
Symptoms   
Typical angina―no. (%) 121 (25) 87(25) 
Atypical angina―no. (%) 288 (61) 213(61) 
Non-anginal chest pain―no. (%) 66 (14) 50(14) 
Electrocardiogram   
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Normal ―no. (%) 372(78) 268(80) 
Left bundle branch block―no. (%) 12 (3) 4(1) 
Left ventricular hypertrophy―no. (%) 5 (1) 4(1) 
Other abnormalities―no. (%) 86 (18) 61(17) 
Left ventricular ejection fraction 36-50%   
≥ 50%―no. (%) 451 (95) 334(95) 
35-50%―no. (%) 24 (5) 16(5) 
Exercise stress test   
Bicycle―no. (%) 267 (56) 204(58) 
Treadmill―no. (%) 114 (24) 90(26) 
Not done―no. (%) 94 (20) 56(16) 
≥ 0.15 mV ST depression ―no. (%) 71 (19) 57(19) 
Probability of CAD by D & F [interquartile range] 65 [33-75] 65[38-78] 
Total Coronary Calcium Score   
0―no. (%) 123 (26) 99(28) 
1-99―no. (%) 107 (22) 85(24) 
100-399―no. (%) 85 (18) 62(18) 
≥ 400―no. (%) 83 (18) 67(19) 
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Not done―no. (%) 77(16) 37(11) 
Invasive coronary angiography   
Not done―no. (%) 168 (35) 97(28) 
Normal vessels―no. (%) 112 (24) 88(25) 
Non-obstructive CAD―no. (%) 55 (12) 52(15) 
One vessel disease―no. (%) 99 (21) 75(21) 
Two vessel disease―no. (%) 25 (5) 22(6) 
Three vessel disease―no. (%) 10 (2) 7(2) 
Left main stem―no. (%) 6 (1) 4(1) 
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Supplemental Table 5. Diagnostic accuracy of imaging techniques for the detection of significant coronary stenoses at ICA using local analysis and including all the 511 patients 
of whom imaging data are available despite some protocol violations. 
Measure of Accuracy Imaging Techniques 
  
CCTA 
(N = 511) 
MPI 
(N = 428) 
WMI 
(N = 388) 
SPECT 
(N = 323) 
PET 
(N = 105) 
ECHO 
(N = 287) 
CMR 
(N = 101) 
Positivity by test - no 163 192 78 162 30 57 21 
Positivity by ICA - no 147 130 109 109 21 77 32 
AUC (95% CI) 
0.92 
(0.89-0.94) 
0.72** 
(0.67-0.76) 
0.70** 
(0.65-0.75) 
0.68 
(0.63-0.73) 
0.83 
(0.73-0.91) 
0.67 
(0.62-0.73) 
0.76 
(0.67-0.85) 
False positive - no 29 94 25 81 13 22 3 
False negative - no 13 32 56 28 4 42 14 
Sensitivity, % (95% CI) 
91 
(86-95) 
75*# 
(67-82) 
49** 
(39-58) 
74 
(66-83) 
81 
(62-95) 
45 
(35-57) 
56 
(38-72) 
Specificity, % (95% CI) 
92 
(89-95) 
68**# 
(63-74) 
91 
(87-94) 
62 
(56-69) 
85 
(76-92) 
90 
(85-93) 
96 
(90-100) 
PPV, % (95% CI) 
82 
(75-88) 
51 
(44-58) 
68 
(56-78) 
50 
(42-58) 
57 
(37-75) 
61 
(48-74) 
86 
(64-97) 
NPV, % (95% CI) 
96 
(94-98) 
86 
(81-91) 
82 
(77-86) 
83 
(76-88) 
95 
(87-99) 
82 
(76-87) 
83 
(72-90) 
 
CCTA = computed coronary tomography angiography; CI = confidence interval; CMR = cardiac magnetic resonance; MPI = myocardial perfusion imaging; PET = positron 
emission tomography; SPECT = single photon computed emission tomography; WMI = wall motion imaging. **P<0.001, *P=0.001 MPI or WMI vs CCTA; #P<0.001 MPI      
vs WMI 
 
 
